Skip to content
OpenCapital
Get started

Kestra Medical Technologies, Ltd. KMTS Q3 2026 earnings

Reported March 17, 2026 · After market close

Revenue$24.6MBeat by $1.7M
EPS-$0.61Miss by $0.01
Revenue estimate$22.9M
EPS estimate-$0.60

Next report

Sep 10, 2026 (in a month)
Revenue estimate$29.0M
EPS estimate-$0.61

Financials

Q3 2026

Income statement

See full
Revenue$24.6M+62.7%
Gross profit$12.9M+97.1%
Operating income-$34.8M-68.8%
Net income-$34.2M-58.8%
EPS (diluted)-$0.61+51.2%

Balance sheet

See full
Cash & equivalents$291.3M+436%
Total debt$43.8M—
Total assets$379.3M—

Cash flow

See full
Operating cash flow-$18.4M-2.1%
CapEx$9.8M+141%
Free cash flow-$28.2M-27.7%

Valuation & ratios

Valuation

as of 01/31/26
See full
Market cap$1.44B—
Enterprise value$1.19B—
P/S17.2×—

Profitability

See full
Gross margin48.8%+15.1pp
Operating margin-171.5%+12.9pp
Net margin-173%+0.8pp
FCF margin-142.9%-25.3pp

Returns & leverage

See full
Current ratio7.3×—

Versus estimates

Revenue

Q4 2026$28.6MBeat by $2.2M
Q3 2026$24.6MBeat by $1.7M
Q3 2025$24.6MBeat by $1.7MQ2 2026$22.6MMiss by $306.7KQ1 2026$19.4MMiss by $1.4MQ4 2025$17.2M

Diluted EPS

Q4 2026-$0.67Miss by $0.08
Q3 2026-$0.61Miss by $0.01
Q3 2025-$0.61Miss by $0.01Q2 2026-$0.62Miss by $0.03Q1 2026-$0.46Beat by $0.20Q4 2025-$1.05

Ask the moment Kestra Medical Technologies, Ltd. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Kestra Medical Technologies, Ltd. report Q3 2026 earnings?
Kestra Medical Technologies, Ltd. (KMTS) reported Q3 2026 earnings on March 17, 2026 after market close.
What were Kestra Medical Technologies, Ltd.'s Q3 2026 revenue and EPS?
Kestra Medical Technologies, Ltd. reported revenue of $24.6M and eps of $-0.61 for Q3 2026.
Did Kestra Medical Technologies, Ltd. beat estimates in Q3 2026?
Revenue beat the consensus estimate of $22.9M by $1.7M. EPS missed the consensus estimate of $-0.60 by $0.01.
How did Kestra Medical Technologies, Ltd.'s Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 0.0% from $24.6M a year earlier and eps grew 0.0% from $-0.61.
Where can I find Kestra Medical Technologies, Ltd.'s Q3 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-110720) and the 10-Q periodic report (0001193125-26-111205) directly on SEC EDGAR. The filing index links above go to sec.gov.